Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments.

Curr Issues Mol Biol · 2025 · PMC12564516 · PMID 41150795

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

SREBP-1c expression was strongly increased, and empagliflozin (EMP) treatment showed a downward trend that did not reach statistical significance ( Figure 4 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.